News

Selling Your Company: How to Respond to An Unsolicited Offer to Buy Your Business

business man on cell phone

You received an inquiry or offer to buy your company – now what?

An unsolicited acquisition offer for your business can come as a surprise. If you haven’t considered selling your company or you are 3-5 years out from your planned exit, you may be caught off guard. This can lead to stress and worry about making the right decision in order maximize the sales price.

No matter what your industry of focus is, there are some key strategies you should employ when faced with an inquiry or offer to acquire your company.  The decision you make must be an informed decision in alignment with your objectives. (more…)

Develop Your Financing Strategy to Attract Capital and Move Beyond Your Initial Seed Stage

From the moment you make a decision to set up and operate a business, you’re in the “business lifecycle.” Fasten your seatbelt before the drive as you’ll journey from idea to startup, and if successful, through to the growth and maturity phases. Each stage of the lifecycle has a unique set of obstacles to deal with and overcome. Being flexible in your thinking and adapting your strategy as you move along will serve you well. This not only applies to a business strategy but also to the financial plans to support the development and growth of the Company. A capital financing strategy should summarize investor targets for outreach by stage of the lifecycle, inflection points and how these will change valuation, and the actions to be taken over a three-to-five year period to achieve the company’s goals in its business evolution. Putting together the strategy is hard work that takes time and considerable thought. Raising money is also hard work, so get started today. (more…)

Presentation Guide for Life Science Companies

Biotechnology DNA Cell Molecule Experiment Research Concept

I’d like to provide my thoughts and guidance to entrepreneurs, founders and business owners in the life sciences sector on what I have seen as successful pitches to investors and strategic companies in the initial pitches of their company and technology. By providing as much of the information noted below during the process, I believe that you can improve the probability and chances of landing a transaction that supports company growth or exit strategies. I have also previously authored related articles on this topic that can be viewed here and here. Happy to clarify any topic if needed. (more…)

Guidance for the Life Science Entrepreneur Looking for Strategic Investments in Their Business: Perfect Your Pitch

This past week, I spent time reviewing the >400 life science opportunities that were presented to me and our investment banking firm in 2017 in which entrepreneurs and business owners were looking for either capital financing, sell-side M&A, strategic advisory services or partnering/ licensing. Nearly invariably, each investment pitch lacked the complete and necessary material to tell the comprehensive story that would be compelling for an investor to write a check. These entrepreneurs are very smart and passionate about their mission but need to recognize and think like investors or strategic buyers. Investors see and hear many investment opportunities and you need to be differentiated and stand out from the masses. (more…)

Symple Surgical, Inc. Retains Objective Capital Partners to Explore Strategic and Financial Partnerships

Symple Surgical Horizontal Logo

San Diego, CA and Flagstaff, AZ, April 12, 2018: — Symple Surgical, Inc., a privately-held, early-stage medical device company focused on developing novel therapeutic technologies using microwave technology for treatment of life-threatening chronic conditions, is pleased to the announce that they have retained Objective Capital Partners as their exclusive financial advisor. Objective Capital Partners, a middle-market Investment Banking firm located in Southern California and focused on mergers & acquisitions (M&A), strategic advisory, capital financing and valuation services, will seek to identify strategic partnerships and financial investors for the Company to progress their lead product Grizzly™ targeting pre-cancerous cells in the elimination of Barrett’s Esophagus and Esophageal Adenocarcinoma, the fastest growing cancer worldwide.

Barrett’s Esophagus (BE) is a premalignant condition caused by stomach acid or gastrointestinal reflux disease (GERD) mutating healthy cells in the lower esophagus into Barrett’s cells.  Approximately 90% of Esophageal Adenocarcinoma (EAC) patients do not receive a prior diagnosis of Barrett’s Esophagus (BE). BE affect’s more than 12 million American adults, and is associated with a 30-fold increased risk of developing EAC. This new treatment will provide an alternative to the Radiofrequency Ablation Technology (“RFA”) and cryoablation technologies currently in use for treatment of BE thereby reducing the number of episodes of treatment and providing unparalleled user control for adequate cell removal.

(more…)

Objective Capital Partners Promotes Michael Kim to Managing Director

San Diego, April 9, 2018 — Objective Capital Partners is pleased to announce the promotion of Michael Kim to Managing Director. Michael contributes over 15 years of mergers & acquisitions (M&A) and corporate finance experience across numerous industries including technology, consumer, and business services. He was also recognized in 2016 by M&A Advisor as a M&A Advisor Emerging Leaders Award Winner.

Mr Kim joined Objective Capital in 2015 and has been responsible for all aspects of  transaction lifecycle including client sourcing, due diligence, negotiation, valuation analyses, and transaction closings. In his new role, Michael will continue serving the firm’s clients in the areas of transaction origination, analysis and execution.

(more…)

Objective Capital’s David H. Crean Receives The 2018 Health Care Heros Award

San Diego Business Journal Health Care Heros Award

San Diego, March 1, 2018 – The San Diego Business Journal’s 2018 Health Care Heroes Awards chose Objective Capital Partners’ David H. Crean, Ph.D. from among the finalists to receive the Health Care Hero Award for Company Executive for his role in healthcare innovation and support.

Leading Objective Capital Partners’ Life Sciences & Healthcare Investment Banking Practice, David leverages more than 20 years of life sciences R&D and corporate development experience. In his Managing Director role, David helps companies secure growth capital, establish strategic partnerships, and achieve exit transactions.

(more…)

Objective Capital’s David H. Crean Named 2017 Thought Leader of the Year

The Alliance of Merger & Acquisition Advisors® (AM&AA)

San Diego, January 30, 2018 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).

The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”

“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage,” said Trever Acers, Managing Director at Objective Capital Partners.  “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives.  David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance.”

(more…)

Community Insights: Understanding Options for Your Business

San Diego, CA- January 23, 2018 – Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that Trever Acers, a Managing Director at the firm, will be presenting at a series of monthly Community Insights alongside Greg Banner, Vice President at Asset Preservation Strategies. This series of discussions is targeted towards business owners to help them understand planning options for their business. The Community Insights series is designed to introduce estate, financial, business, real estate as well as long-term care planning clients to the various options that facilitate achieving their goals.

There is no cost to attend the Community Insights series but you must register online at:

www.ComIns-BFTandObjCap.com

(more…)

Objective Capital Partners Trever Acers Honored in 2018 San Diego’s 500 Influential Business Leader List

San Diego, CA- December 18, 2017 – Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that Trever Acers, a Managing Director at the firm, has been recognized by the San Diego Business Journal in the 2018 edition of the San Diego 500, The Book of Influential Business Leaders. The publication’s editorial team selected the honorees from every sector of the San Diego Business community. (more…)

Objective Capital’s David H. Crean Named 2017 Finalist for Thought Leader of the Year

San Diego, December 12, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been selected as top five national finalist for the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA). For more information on the Award and the Finalists, please visit http://www.amaaonline.com/thought-leader-of-the-year/ (more…)

Life Sciences Tools, Diagnostics, & Services Industry Report 11/2017

Objective Capital Partners has expertise in four industry sectors: Business Services, Consumer, Life Sciences & Healthcare, and Technology. As part of our ongoing efforts in the Life Sciences and Healthcare space, we have developed specific expertise in Life Science Tools. In fact, we recently closed an interesting transaction in the life sciences services space.

We are pleased to share our research in the attached report that can be downloaded for your review. Please feel free to reach out to us to discuss further.

 

DOWNLOAD

 

Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks

Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017

San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker. (more…)

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

 

Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County’s CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO. (more…)

Objective Capital Partners Wins Four Awards at Advisor of the Year 2017

SAN DIEGO (October 30, 2017) — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that it has been awarded four Advisor of the Year awards including Best Sell-side Representation by an Investment Banker for a transaction more than $25M. Objective Capital won the Advisor of the Year awards in the following categories:

  • Best Sell-side Representation by an Investment Banker more than $25M for its advisory of GunVault and Cannon Safe in its sale to MidOcean Partners;
  • Best Sell-side Representation by an Investment Banker less than $25M for its advisory of Troxel Helmets in its sale to Weaver Leather;
  • Special Situation Advisory for its advisory of Minimal Invasive Devices in its sale to Cagan McAfee Capital Partners;
  • Contribution related to Valuation for its advisory to the internal sale of an undisclosed business services company.

(more…)

Objective Capital Partners Announced as Finalist in Seven Categories for Advisor of the Year Awards

SAN DIEGO (October 23, 2017) — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce it has been selected as a finalist in seven categories for Advisor of the Year 2017. These awards acknowledge middle market mergers and acquisitions professionals who have significantly contributed to the successful sale, expansion or recapitalization of their clients’ companies in the San Diego region. (more…)

M&A Deal Represented by Objective Capital Partners Selected as Finalist by The M&A Advisor

Information Technology Deal of the Year Finalist

New York, NY and San Diego, CA- October 11, 2017 –  The M&A Advisor is pleased to announce that one of the deals represented by Objective Capital Partners, a middle-market investment banking firm located in Southern California, was selected as a Finalist in the category for Information Technology Deal of The Year for the 16th Annual M&A Advisor Awards.  Objective Capital Partners served as the exclusive financial advisor to an undisclosed digital healthcare company on its confidential sale to a large private equity-backed acquirer.  Two other advisers on the deal included Kirkland & Ellis LLP and Sheppard Mullin Richter & Hampton LLP.  This is the third time in as many years that a deal represented by the investment banking firm was selected as a Finalist by the M&A Advisor. (more…)

Channing Hamlet to Keynote “What’s Your Business Really Worth?”

San Diego, CA- October 4, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that Channing, Hamlet, one of its Managing Directors, will serve as Keynote Speaker as part of the Million Dollar Curriculum on “What’s Your Business Really Worth?”. The program will be held on October 11, 2017 at Corporate Alliance Center, 9171 Towne Centre Drive, San Diego, CA 92122 from 8 AM- 12 PM. The event is sponsored and presented by Cade & Company. (more…)

NRC Health and Practicing Excellence Form Strategic Alliance

Objective Capital Partners Acted as Financial Advisor to Practicing Excellence

San Diego, CA- September 25, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Practicing Excellence upon its strategic alliance with and investment from NRC Health. Practicing Excellence, the developer of an online skill-building platform, connects clinicians to practical, evidence-based, colleague-tested tools designed to enhance the delivery of patient care and improve the overall physician experience. (more…)

Weaver Leather, LLC, Acquires Troxel Helmets

Objective Capital Partners Acted as Exclusive Financial Advisor to Troxel

San Diego, CA- September 5, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Troxel, the world’s leading provider of ASTM/SEI certified equestrian helmets, upon its acquisition by Weaver Leather, LLC. Objective Capital Partners acted as exclusive financial advisor to Troxel. (more…)

Cagan McAfee Capital Partners Teams with Myles Sherman to Acquire Minimally Invasive Devices

Objective Capital Partners Acted as Financial Advisor to MID

 San Diego, CA- August 21, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Minimally Invasive Devices (MID), privately-held medical device and market leading laparoscopic surgery solutions company, upon its acquisition by Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX. Objective Capital Partners acted as financial advisors to MID. (more…)

Objective Capital Partners’ Trever Acers to Address Business Exit Strategies at September ACG San Diego Event

Managing Director to Discuss Exit Options for Business Owners and C-Level Executives

San Diego, CA- August 10, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Trever Acers, will serve on a panel of experts at the September event of the Association for Corporate Growth San Diego (ACG San Diego). The event entitled, “What’s Your Exit Strategy”, will be held on September 19, 2017 from 7-9 AM at Lomas Santa Fe Country Club in Solana Beach, CA.  Business Owners and C-level executives are encouraged to attend a Private Company Forum (PCF) from 9-10 AM.   (more…)

Cannon Safe Announces Partnership with MidOcean Partners To Acquire Stack-On Products

Objective Capital Partners Acted as Financial Advisor to Cannon Safe

San Diego, CA- August 7, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Cannon Safe, Inc.  Cannon Safe, the market leader in the start-to-finish manufacturing of large scale residential safes and the leading innovator of quick-access home defense safes under the GunVault brand, recently announced a partnership with MidOcean Partners, a premier middle market private equity firm focused on consumer and business services, to acquire Stack-On Products, a market leader in secure storage and home organization. (more…)

ACG San Diego Elects Objective Capital Partners’ Crean to Its Board of Directors

Managing Director to Serve as Chair of Marketing Committee

San Diego, CA- August 1, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., was elected to serve on the Board of Directors for the San Diego Chapter of the Association for Corporate Growth (ACG San Diego).  The Chapter also added Jay Robinson-Duff, VP, First American Trust to its Board.  Dr. Crean has been a member of ACG for the past two years and will lead the Chapter’s marketing efforts.  At Objective Capital Partners, he is responsible for the firm’s strategy targeted at companies in the Healthcare and Life Sciences sector including pharmaceutical, biotechnology, medical technology, medical device, supplies, manufacturing and life science tools/ diagnostic firms looking for M&A, partnering, strategic advisory and capital financing options. (more…)

Business Exit Planning, Getting a Business Ready for Sale and Building Business Value

Objective Capital Partners’ Trever Acers to Address
North County Estate Planning Council of San Diego on August 1, 2017

San Diego, CA- July 24, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Trever Acers, will be a panel speaker at the North County Estate Planning Council of San Diego on Tuesday, August 1, 2017. Mr. Acers will address Building and Protecting Business Value to Maximize Realized Dollars and Achieving Transaction Readiness and will be joined by fellow panelists Bob Copeland of Sheppard Mullin and Keith Troutman of Squar Milner. The event will be held at Morgan Run Club & Resort, 5690 Cancha de Golf, Rancho Santa Fe, CA 92091 from 7-9 AM. The guest fee for non-members is $30 and members attend free of charge. (more…)